Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma.

Kamimura, Kenya; Suda, Takeshi; Tamura, Yasushi; Takamura, Masaaki; Yokoo, Takeshi; Igarashi, Masato; Kawai, Hirokazu; Yamagiwa, Satoshi; Nomoto, Minoru; Aoyagi, Yutaka

Kamimura, Kenya; Suda, Takeshi; Tamura, Yasushi; Takamura, Masaaki; Yokoo, Takeshi; Igarashi, Masato; Kawai, Hirokazu; Yamagiwa, Satoshi; Nomoto, Minoru; Aoyagi, Yutaka.

Affiliation

Kamimura K; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan.

BMC Gastroenterol ; 12: 127, 2012 Sep 20.

Article in En | MEDLINE | ID: mdl-22994941

Subject(s)

Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Hepatocellular/drug therapy; Cisplatin/therapeutic use; Liver Neoplasms/drug therapy; Organoplatinum Compounds/therapeutic use; Aged; Aged, 80 and over; Antineoplastic Agents/pharmacokinetics; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics; Cisplatin/pharmacokinetics; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds/pharmacokinetics; Powders

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Organoplatinum Compounds / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google